Metal-organic frameworks as potential drug delivery systems

Expert Opinion on Drug Delivery

Volumn 10, Issue 1, 2013, Pages 89-101

  Sun, Chun Yi ^a   Qin, Chao ^a   Wang, Xin Long ^a   Su, Zhong Min ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Controlled release; Drug delivery; Metal organic frameworks; Nanocarriers

Indexed keywords

AZIDOTHIMIDIN TRIPHOSPHATE; BUSULFAN; CIDOFOVIR; CISPLATIN; DOXORUBICIN; DRUG CARRIER; IBUPROFEN; METAL ORGANIC FRAMEWORK; PHOSPHATE; UNCLASSIFIED DRUG;

BIODEGRADABILITY; BIOMEDICINE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; MICROEMULSION; NONHUMAN; PARTICLE SIZE; POROSITY; REVIEW; SURFACE PROPERTY; SYNTHESIS;

ADSORPTION; ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; ORGANOMETALLIC COMPOUNDS; PARTICLE SIZE; POROSITY;

EID: 84871462305     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.741583     Document Type: Review

References (71)

1. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-60 (Pubitemid 40282557)
2. Yoo JW, Lee CH. Drug delivery systems for hormone therapy. J Control Release 2006;112:1-14
3. Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of skin diseases. Exper Opin Drug Deliv 2012;9:783-804
4. Vallet-Reg M, Balas F, Arcos D. Mesoporous materials for drug delivery. Angew Chem Int Ed 2007;46:7548-58 (Pubitemid 47556998)
5. Davis ME, Chen Z, Shin DM. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82
6. Dyson PJ, Sava G. Metal-based antitumour drugs in the post genomic era. Dalton Trans 2006;16:1929-33 (Pubitemid 43797525)
7. Fathabadi EG, Shelling AN, Al-Kassas R. Nanocarrier systems for delivery of siRNA to ovarian cancer tissues. Exper Opin Drug Deliv 2012;9:743-54
8. Soppimath KS, Aminabhavi TM, Kulkarni AR, et al. Biodegradable polymeric nanoparticles as drug delivery systems. J Control Release 2001;70:1-20 (Pubitemid 32144788)
9. Dhivanand P, Sprockel OL. A controlled porosity drug delivery system. Int J Pharm 1998;167:83-96
10. Vallet-Regi M, Ramila A, del Real RP, Perez-Pariente J. A new property of MCM-41: drug delivery system. Chem Mater 2001;13:308-11 (Pubitemid 32199334)
11. Wang XL, Qin C, Wu SX, et al. Bottom-up synthesis of porous coordination frameworks: apical substitution of a pentanuclear tetrahedral precursor. Angew Chem Int Ed 2009;48:5291-5
12. Seo JS, Whang D, Lee H, et al. A homochiral metal-organic porous material for enantioselective separation and catalysis. Nature 2000;404:982-6 (Pubitemid 30243589)
13. Serra-Crespo P, van der Veen MA, Gobechiya E, et al. NH2-MIL-53(Al): a high-contrast reversible solid-state nonlinear optical switch. J Am Chem Soc 2012;134:8314-17
14. Allendorf MD, Bauer CA. Bhakta, RK, et al. Luminescent metal-organic frameworks. Chem Soc Rev 2009;38:1330-52
15. Eddaoudi M, Kim J, Rosi N, et al. Systematic design of pore size and functionality in isoreticular MOFs and their application in methane storage. Science 2002;295:469-72 (Pubitemid 34101630)
16. Yuan D, Zhao D, Sun D, et al. An isoreticular series of metal-organic frameworks with dendritic hexacarboxylate ligands and exceptionally high gas-uptake capacity. Angew Chem Int Ed 2010;49:5357-61
17. Qin JS, Du DY, Li WL, et al. N-rich zeolite-like metal-organic framework with sodalite topology: high CO2 uptake, selective gas adsorption and efficient drug delivery. Chem Sci 2012;3:2114-18
18. Lee CY, Bae YS, Jeong NC, et al. Kinetic separation of propene and propane in metal-organic frameworks: controlling diffusion rates in plate-shaped crystals via tuning of pore apertures and crystallite aspect ratios. J Am Chem Soc 2011;133:5228-31
19. Kitaura R, Fujimoto K, Noro S, et al. A pillared-layer coordination polymer network displaying hysteretic sorption: [Cu2(pzdc)2(dpyg)]n (pzdc = pyrazine-2,3-dicarboxylate; dpyg = 1,2-Di(4-pyridyl)glycol). Angew Chem Int Ed 2002;41:133-5 (Pubitemid 34076124)
20. Lan YQ, Jiang HL, Li SL. Mesoporous metal-organic frameworks with size-tunable cages: selective CO2 uptake, encapsulation of Ln3+ cations for luminescence, and column-chromatographic dye separation. Adv Mater 2011;23:5015-20
21. Imaz I, Rubio-Marti'nez M, An J, et al. Metal-biomolecule frameworks (MBioFs). Chem Commun 2011;47:7287-302
22. Furukawa H, Ko N, Go YB, et al. Ultrahigh porosity in metal-organic frameworks. Science 2010;329:424-8
23. Morris RE, Wheatley PS. Gas storage in nanoporous materials. Angew Chem Int Ed 2008;47:4966-81
24. Horcajada P, Chalati T, Serre C, et al. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Nat Mater 2010;9:172-6
25. Bertini I. Biological inorganic chemistry: structure and reactivity. University Science Books; Sausalito, CA: 2007
26. Horcajada P, Gref R, Baati T, et al. Metal-organic frameworks in biomedicine. Chem Rev 2012;112:1232-68
27. Mizutani M, Maejima N, Jitsukawa K, et al. An infinite chiral single-helical structure formed in Cu(II)-L-/D-glutamic acid system. Inorg Chim Acta 1998;283:105-10 (Pubitemid 128354329)
28. An J, Geib SJ, Rosi NL, et al. Cation-triggered drug release from a porous zinc-adeninate metal-organic framework. J Am Chem Soc 2009;131:8376-7
29. Smaldone RA, Forgan RS, Furukawa H, et al. Metalorganic frameworks from edible natural products. Angew Chem Int Ed 2010;49:8630-4
30. McKinlay AC, Morris RE, Horcajada P, et al. BioMOFs: metal-organic frameworks for biological and medical applications. Angew Chem Int Ed 2010;49:6260-6
31. Horcajada P, Serre C, Vallet-Reg M, et al. Metal-organic frameworks as efficient materials for drug delivery. Angew Chem Int Ed 2006;45:5974-8 (Pubitemid 44408681)
32. Horcajada P, Serre C, Maurin G, et al. Flexible porous metal-organic frameworks for a controlled drug delivery. J Am Chem Soc 2008;130:6774-80 (Pubitemid 351748413)
33. Sun CY, Qin C, Wang XL, et al. Zeolitic imidazolate framework-8 as efficient pH-sensitive drug delivery vehicle. Dalton Trans 2012;41:6906-9
34. Doane TL, Burda C. The unique role of nanoparticles in nanomedicine: imaging, drug delivery. Chem Soc Rev 2012;41:2885-911
35. Chalati T, Horcajada P, Gref R, et al. Optimisation of the synthesis of MOF nanoparticles made of flexible porous iron fumarate MIL-88A. J Mater Chem 2011;21:2220-7
36. Hermes S, Witte T, Hikov T, et al. Trapping metal-organic framework nanocrystals: an in-situ time-resolved light scattering study on the crystal growth of MOF-5in solution. J Am Chem Soc 2007;129:5324-5 (Pubitemid 46697596)
37. Horcajada P, Serre C, Grosso D, et al. Colloidal route for preparing optical thin films of nanoporous metal-organic frameworks. Adv Mater 2009;21:1931-5
38. Cravillon J, Munzer S, Lohmeier SJ, et al. Rapid room-temperature synthesis and characterization of nanocrystals of a prototypical zeolitic imidazolate framework. Chem. Mater 2009;21:1410-12
39. Cho W, Lee HJ, Oh MJ. Growth-controlled formation of porous coordination polymer particles. J Am Chem Soc 2008;130:16943-6
40. Rieter WJ, Taylor KML, An H, et al. Nanoscale metal organic frameworks as potential multimodal contrast enhancing agents. J Am Chem Soc 2006;128:9024-5 (Pubitemid 44078972)
41. Qiu LG, Li ZQ, Wu Y, et al. Facile synthesis of nanocrystals of a microporous metal-organic framework by an ultrasonic method and selective sensing of organoamines. Chem. Commun 2008;3642-4
42. Jhung SH, Lee JH, Yoon JW, et al. Microwave synthesis of chromium terephthalate MIL-101 and its benzene sorption ability. Adv Mater 2007;19:121-4 (Pubitemid 46144822)
43. Taylor KML, Rieter WJ, Lin W. Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. J Am Chem Soc 2008;130:14358-9
44. Taylor-Pashow KML, Rocca JDe, Xie Z, et al. Postsynthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery. J Am Chem Soc 2009;131:14261-3
45. Gref R, Domb A, Quellec P, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 1995;16:215-33
46. Horcajada P, Ma'rquez-Alvarez C, Ra'mila A, et al. Controlled release of Ibuprofen from dealuminated faujasites. Solid State Sci 2006;8:1459-65 (Pubitemid 44854614)
47. Walko CM, Lindley C. Capecitabine: a review. Clin Ther 2005;27:23-44 (Pubitemid 40347299)
48. Scalvini A, Ferrari V, Bodei S, et al. Involvement of target gene polymorphisms in 5-fluorouracil toxicity: a Case Report. Pharmacology 2012;89:99-102
49. Yi H, Cho HJ, Cho SM, et al. Research article pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel. BMC Cancer 2010;10:211-18
50. Wang HN, Meng X, Yang GS, et al. Stepwise assembly of metal-organic framework based on a metal-organic polyhedron precursor for drug delivery. Chem Commun 2011;47:7128-30
51. Li XL, Li H, Liu GQ, et al. Magnetite-loaded fluorine-containing polymeric micelles for magnetic resonance imaging and drug delivery. Biomaterials 2012;33:3013-24
52. Wang HN, Meng X, Wang XL, et al. Auxiliary ligand induced structural allomorphism in nanotubular microporous metal-organic frameworks based on discrete magnesium clusters. Dalton Trans 2012;41:2231-3
53. Sun CY, Qin C, Wang CG. Chiral Nanoporous metal-organic frameworks with high porosity as materials for drug delivery. Adv Mater 2011;23:5629-32
54. Jung J, Lee IH, Lee E, et al. pH-sensitive polymer nanospheres for use as a potential drug delivery vehicle. Biomacromolecules 2007;8:3401-7 (Pubitemid 350193739)
55. Park KS, Ni Z, Côté AP, et al. Exceptional chemical and thermal stability of zeolitic imidazolate frameworks. Proc Natl Acad Sci USA 2006;103:10186-91 (Pubitemid 44051141)
56. Banerjee R, Phan A, Wang B, et al. High-throughput synthesis of zeolitic imidazolate frameworks and application to CO2 capture. Science 2008;319:939-43 (Pubitemid 351263761)
57. Shi Q, Chen ZF, Song ZW, et al. Synthesis of ZIF-8 and ZIF-67 by steam-assisted conversion and an investigation of their tribological behaviors. Angew Chem Int Ed 2011;50:672-5
58. An J, Geib SJ, Rosi NL. Cation-triggered drug release from a porous zinc adeninate metal-organic framework. J Am Chem Soc 2009;131:8376-7
59. Rocca JD, Liu D, Lin W. Nanoscale metal-organic frameworks for biomedical imaging and drug delivery. Acc Chem Res 2011;44:957-68
60. Taylor-Pashow KML, Rocca JD, Xie Z, et al. Postsynthetic modifications of iron-carboxylate nanoscale metal-organic frameworks for imaging and drug delivery. J Am Chem Soc 2009;131:14261-3
61. Loehrer PJ, Einhorn LH. Drugs five years later. Cisplatin. Ann Intern Med 1984;100:704-13
62. Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 2003;10:1663-82
63. Pinzani V, Bressolle F, Johannehaug I, et al. Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemoth Pharm 1994;35:1-9 (Pubitemid 24356740)
64. Hartmann JT, Kollmannsberger C, Kanz L, et al. Platinum organtoxicity and possible prevention in patients with testicular cancer. Int J Cancer 1999;83:866-9
65. Bosch ME, Sanchez AJ, Rojas FS, et al. Analytical methodologies for the determination of cisplatin. J Pharmceut Biomed 2008;47:451-9
66. Giaccone G. Clinical perspectives on platinum resistance. Drugs 2000;59:9-17 (Pubitemid 30344987)
67. Miller SR, Heurtaux D, Baati T, et al. Biodegradable therapeutic MOFs for the delivery of bioactive molecules. Chem Commun 2010;46:4526-8
68. Ahmad S, Isab AA, Ali S, et al. Perspectives in bioinorganic chemistry of some metal based therapeutic agents. Polyhedron 2006;25:1633-45
69. de Paiva REF, Abbehausen C, Gomes AF, et al. Synthesis, spectroscopic characterization, DFT studies and antibacterial assays of a novel silver(I) complex with the anti-inflammatory nimesulide. Polyhedron 2012;36:112-19
70. Xiao B, Wheatley PS, Zhao X, et al. High-capacity hydrogen and nitric oxide adsorption and storage in a metal-organic framework. J Am Chem Soc 2007;129:1203-9 (Pubitemid 46208590)
71. McKinlay AC, Xiao B, Wragg DS, et al. Exceptional behavior over the whole adsorption-storage-delivery cycle for NO in porous metal organic frameworks. J Am Chem Soc 2008;130:10440-4